Advisors Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.31M | Sell |
3,952
-351
| -8% | -$119K | 0.02% | 724 |
|
|
2025
Q4 | $1.71M | Sell |
4,303
-219
| -5% | -$96.9K | 0.03% | 642 |
|
|
2025
Q3 | $2.06M | Sell |
4,522
-23
| -0.5% | -$9.37K | 0.04% | 589 |
|
|
2025
Q2 | $1.48M | Sell |
4,545
-1,306
| -22% | -$361K | 0.03% | 657 |
|
|
2025
Q1 | $1.58M | Buy |
5,851
+204
| +4% | +$52.4K | 0.03% | 622 |
|
|
2024
Q4 | $1.33M | Buy |
5,647
+880
| +18% | +$231K | 0.02% | 672 |
|
|
2024
Q3 | $1.31M | Buy |
4,767
+189
| +4% | +$49.2K | 0.02% | 670 |
|
|
2024
Q2 | $1.11M | Buy |
4,578
+541
| +13% | +$85.4K | 0.02% | 696 |
|
|
2024
Q1 | $603K | Buy |
4,037
+2,664
| +194% | +$444K | 0.01% | 860 |
|
|
2023
Q4 | $263K | Buy |
1,373
+81
| +6% | +$13.8K | 0.01% | 1066 |
|
|
2023
Q3 | $229K | Buy |
1,292
+375
| +41% | +$71.5K | ﹤0.01% | 1078 |
|
|
2023
Q2 | $174K | Sell |
917
-34
| -4% | -$6.74K | ﹤0.01% | 1142 |
|
|
2023
Q1 | $191K | Sell |
951
-5
| -0.5% | -$1.05K | ﹤0.01% | 1124 |
|
|
2022
Q4 | $227K | Sell |
956
-1,429
| -60% | -$305K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $477K | Sell |
2,385
-469
| -16% | -$89.5K | 0.01% | 941 |
|
|
2022
Q2 | $416K | Sell |
2,854
-1,082
| -27% | -$153K | 0.01% | 992 |
|
|
2022
Q1 | $643K | Buy |
3,936
+292
| +8% | +$44.5K | 0.01% | 939 |
|
|
2021
Q4 | $618K | Sell |
3,644
-49
| -1% | -$9.11K | 0.01% | 945 |
|
|
2021
Q3 | $697K | Buy |
3,693
+8
| +0.2% | +$1.5K | 0.01% | 919 |
|
|
2021
Q2 | $625K | Sell |
3,685
-1,232
| -25% | -$180K | 0.01% | 951 |
|
|
2021
Q1 | $694K | Buy |
4,917
+379
| +8% | +$57K | 0.01% | 938 |
|
|
2020
Q4 | $590K | Buy |
4,538
+688
| +18% | +$91.9K | 0.01% | 917 |
|
|
2020
Q3 | $561K | Sell |
3,850
-575
| -13% | -$81.7K | 0.01% | 888 |
|
|
2020
Q2 | $655K | Sell |
4,425
-689
| -13% | -$92.9K | 0.01% | 813 |
|
|
2020
Q1 | $557K | Sell |
5,114
-2,927
| -36% | -$338K | 0.01% | 790 |
|
|
2019
Q4 | $926K | Buy |
8,041
+1,447
| +22% | +$144K | 0.02% | 785 |
|
|
2019
Q3 | $530K | Sell |
6,594
-7,448
| -53% | -$589K | 0.01% | 956 |
|
|
2019
Q2 | $1.02M | Sell |
14,042
-3,622
| -21% | -$278K | 0.02% | 776 |
|
|
2019
Q1 | $1.65M | Sell |
17,664
-219
| -1% | -$18.3K | 0.03% | 635 |
|
|
2018
Q4 | $1.3M | Buy |
17,883
+155
| +0.9% | +$11.9K | 0.03% | 672 |
|
|
2018
Q3 | $1.55M | Buy |
17,728
+727
| +4% | +$73.1K | 0.03% | 692 |
|
|
2018
Q2 | $1.67M | Buy |
17,001
+2,298
| +16% | +$228K | 0.03% | 653 |
|
|
2018
Q1 | $1.77M | Buy |
14,703
+726
| +5% | +$93.6K | 0.03% | 638 |
|
|
2017
Q4 | $1.78M | Buy |
13,977
+1,025
| +8% | +$129K | 0.03% | 652 |
|
|
2017
Q3 | $1.52M | Buy |
12,952
+4,332
| +50% | +$370K | 0.03% | 702 |
|
|
2017
Q2 | $688K | Sell |
8,620
-875
| -9% | -$55.9K | 0.01% | 998 |
|
|
2017
Q1 | $487K | Sell |
9,495
-13,423
| -59% | -$620K | 0.01% | 1111 |
|
|
2016
Q4 | $858K | Sell |
22,918
-3,308
| -13% | -$139K | 0.01% | 939 |
|
|
2016
Q3 | $1.78M | Sell |
26,226
-21,893
| -45% | -$1.54M | 0.03% | 662 |
|
|
2016
Q2 | $2.67M | Sell |
48,119
-4,806
| -9% | -$303K | 0.04% | 560 |
|
|
2016
Q1 | $3.32M | Sell |
52,925
-11,902
| -18% | -$791K | 0.06% | 488 |
|
|
2015
Q4 | $6.1M | Buy |
64,827
+226
| +0.3% | +$21K | 0.1% | 294 |
|
|
2015
Q3 | $5.19M | Buy |
64,601
+9,681
| +18% | +$1.08M | 0.08% | 335 |
|
|
2015
Q2 | $6.58M | Buy |
54,920
+8,250
| +18% | +$986K | 0.09% | 307 |
|
|
2015
Q1 | $4.87M | Buy |
46,670
+13,912
| +42% | +$1.41M | 0.06% | 379 |
|
|
2014
Q4 | $3.18M | Buy |
32,758
+9,676
| +42% | +$896K | 0.04% | 487 |
|
|
2014
Q3 | $1.8M | Buy |
23,082
+10,166
| +79% | +$656K | 0.02% | 646 |
|
|
2014
Q2 | $816K | Buy |
12,916
+7,968
| +161% | +$474K | 0.01% | 884 |
|
|
2014
Q1 | $332K | Buy |
+4,948
| New | +$383K | 0.01% | 1121 |
|
Other funds holding ALNY
VPM
VCM
